Literature DB >> 26634687

An overview of the genetics, mechanisms and management of NAFLD and ALD.

Rachel J Rowell1, Quentin M Anstee2.   

Abstract

Alcoholic liver disease (ALD) and, increasingly, non-alcoholic fatty liver disease (NAFLD) are common causes of advanced liver disease in many developed countries including the UK. Both diseases share parallel natural histories, progressing from steatosis, to steatohepatitis and fibrosis/cirrhosis; and are characterised by substantial interindividual variation in disease outcome. This article will provide an overview of disease mechanisms, genetic modifiers and management, focusing principally on NAFLD, while drawing parallels between the two conditions where appropriate. © Royal College of Physicians 2015. All rights reserved.

Entities:  

Keywords:  NAFLD; alcohol; cirrhosis; fatty liver; gene

Mesh:

Year:  2015        PMID: 26634687     DOI: 10.7861/clinmedicine.15-6-s77

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  10 in total

1.  Racial Disparities in Associations of Alcohol Consumption With Liver Disease Mortality in a Predominantly Low-Income Population: A Report From the Southern Community Cohort Study.

Authors:  Lei Fan; Xiangzhu Zhu; Alexandra Shingina; Edmond K Kabagambe; Martha J Shrubsole; Qi Dai
Journal:  Am J Gastroenterol       Date:  2022-04-13       Impact factor: 12.045

Review 2.  Treatment options for alcoholic and non-alcoholic fatty liver disease: A review.

Authors:  Sukhpreet Singh; Natalia A Osna; Kusum K Kharbanda
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

3.  The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais.

Authors:  Abhasnee Sobhonslidsuk; Suwannee Chanprasertyothin; Tanjitti Pongrujikorn; Piyaporn Kaewduang; Kwannapa Promson; Supanna Petraksa; Boonsong Ongphiphadhanakul
Journal:  Biomed Res Int       Date:  2018-01-16       Impact factor: 3.411

4.  Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population.

Authors:  Yuan Li; Shousheng Liu; Yuqiang Gao; Huan Ma; Shuhui Zhan; Yan Yang; Yongning Xin; Shiying Xuan
Journal:  BMC Biochem       Date:  2019-02-06       Impact factor: 4.059

5.  NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice.

Authors:  Xiwen Xiong; Jiahui Yu; Rui Fan; Cuicui Zhang; Lin Xu; Xupeng Sun; Yanmei Huang; Qingzhi Wang; Hai-Bin Ruan; Xinlai Qian
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

Review 6.  Physical exercise and liver "fitness": Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease.

Authors:  Jelena Stevanović; Jorge Beleza; Pedro Coxito; António Ascensão; José Magalhães
Journal:  Mol Metab       Date:  2019-11-29       Impact factor: 7.422

7.  Morphofunctional State and Circadian Rhythms of the Liver under the Influence of Chronic Alcohol Intoxication and Constant Lighting.

Authors:  Maria A Kozlova; Yuri A Kirillov; Lyudmila A Makartseva; Igor Chernov; David A Areshidze
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

Review 8.  Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?

Authors:  Shivaram P Singh; Prajna Anirvan; Reshu Khandelwal; Sanjaya K Satapathy
Journal:  J Clin Transl Hepatol       Date:  2021-08-24

Review 9.  Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine.

Authors:  Mingmei Shao; Yifei Lu; Hongjiao Xiang; Junmin Wang; Guang Ji; Tao Wu
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

10.  Higher Weight Variability Could Bring You a Fatty Liver.

Authors:  Yeoree Yang; Jae-Hyoung Cho
Journal:  Endocrinol Metab (Seoul)       Date:  2021-08-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.